Tatva Chintan Pharma [TATVA] vs Tanfac Industries [TANFACIND] Detailed Stock Comparison

Tatva Chintan Pharma Chem Limited

NSE
Loading...

Tanfac Industries Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Tatva Chintan Pharma Chem Limited wins in 8 metrics, Tanfac Industries Ltd. wins in 12 metrics, with 0 ties. Tanfac Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Tatva Chintan Pharma Chem Limited Tanfac Industries Ltd. Better
P/E Ratio (TTM) 93.92 66.26 Tanfac Industries Ltd.
Price-to-Book Ratio 4.10 14.61 Tatva Chintan Pharma Chem Limited
Debt-to-Equity Ratio 11.00 9.28 Tanfac Industries Ltd.
PEG Ratio 0.01 -0.85 Tatva Chintan Pharma Chem Limited
EV/EBITDA 47.12 41.73 Tanfac Industries Ltd.
Profit Margin (TTM) 6.83% 10.85% Tanfac Industries Ltd.
Operating Margin (TTM) 12.50% 12.17% Tatva Chintan Pharma Chem Limited
EBITDA Margin (TTM) 12.50% 12.17% Tatva Chintan Pharma Chem Limited
Return on Equity 0.77% 28.25% Tanfac Industries Ltd.
Return on Assets (TTM) 0.68% 20.67% Tanfac Industries Ltd.
Free Cash Flow (TTM) $-516.01M $-641.87M Tatva Chintan Pharma Chem Limited
Dividend Yield 0.10% 0.34% Tanfac Industries Ltd.
1-Year Return 25.48% 29.08% Tanfac Industries Ltd.
Price-to-Sales Ratio (TTM) 6.45 7.19 Tatva Chintan Pharma Chem Limited
Enterprise Value $31.54B $49.64B Tanfac Industries Ltd.
EV/Revenue Ratio 6.58 7.20 Tatva Chintan Pharma Chem Limited
Gross Profit Margin (TTM) 58.01% 36.49% Tatva Chintan Pharma Chem Limited
Revenue per Share (TTM) $205 $346 Tanfac Industries Ltd.
Earnings per Share (Diluted) $14.07 $37.53 Tanfac Industries Ltd.
Beta (Stock Volatility) 0.34 -0.21 Tanfac Industries Ltd.

Tatva Chintan Pharma Chem Limited vs Tanfac Industries Ltd. Stock Performance Analysis

Loading Price Chart...

TATVA
TANFACIND

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Tatva Chintan Pharma Chem Limited-0.64%5.11%-8.88%7.24%-16.21%-10.09%
Tanfac Industries Ltd.-0.28%-2.58%-18.82%-1.31%-0.16%-7.86%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Tatva Chintan Pharma Chem Limited25.48%-31.35%-50.03%-50.03%-50.03%-50.03%
Tanfac Industries Ltd.29.08%107.16%1,664.40%11,884.41%13,950.69%11,143.65%

Performance & Financial Health Analysis: Tatva Chintan Pharma Chem Limited vs Tanfac Industries Ltd.

MetricTATVATANFACIND
Market Information
Market Cap i₹29.71B₹49.61B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i49,50722,308
90 Day Avg. Volume i48,93816,696
Last Close₹1,183.50₹1,979.15
52 Week Range₹886.00 - ₹1,610.00₹1,450.55 - ₹2,585.00
% from 52W High-26.49%-23.44%
All-Time High₹2,977.80 (Nov 01, 2021)₹5,064.30 (Aug 29, 2025)
% from All-Time High-60.26%-60.92%
Growth Metrics
Quarterly Revenue Growth0.53%-0.03%
Quarterly Earnings Growth108.89%-0.55%
Financial Health
Profit Margin (TTM) i0.07%0.11%
Operating Margin (TTM) i0.13%0.12%
Return on Equity (TTM) i0.01%0.28%
Debt to Equity (MRQ) i11.009.28
Cash & Liquidity
Book Value per Share (MRQ)₹322.54₹170.18
Cash per Share (MRQ)₹7.35₹14.38
Operating Cash Flow (TTM) i₹145.88M₹523.26M
Levered Free Cash Flow (TTM) i₹57.13M₹881.47M
Dividends
Last 12-Month Dividend Yield i0.10%0.34%
Last 12-Month Dividend i₹1.00₹16.00

Valuation & Enterprise Metrics Analysis: Tatva Chintan Pharma Chem Limited vs Tanfac Industries Ltd.

MetricTATVA (Apr 24, 2026)TANFACIND (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i93.9266.26
Forward P/E i45.99N/A
PEG Ratio i0.01-0.85
Price to Sales (TTM) i6.457.19
Price to Book (MRQ) i4.1014.61
Market Capitalization
Market Capitalization i₹29.71B₹49.61B
Enterprise Value i₹31.54B₹49.64B
Enterprise Value Metrics
Enterprise to Revenue i6.587.20
Enterprise to EBITDA i47.1241.73
Risk & Other Metrics
Beta i0.34-0.21
Book Value per Share (MRQ) i₹322.54₹170.18

Financial Statements Comparison: Tatva Chintan Pharma Chem Limited vs Tanfac Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTATVA (2025)TANFACIND (2025)
Revenue/Sales i3.80B5.51B
Cost of Goods Sold i2.08B3.18B
COGS % of Revenue i54.7%57.8%
Gross Profit i1.72B2.32B
Gross Margin i45.3%42.2%
Research & Development iN/AN/A
Operating Income (EBIT) i69.09M1.21B
Operating Margin i1.8%22.0%
EBITDA i361.82M1.29B
EBITDA Margin i9.5%23.4%
Pre-Tax Income i75.79M1.19B
Pre-Tax Income % of Revenue i2.0%21.6%
Income Tax i18.66M306.14M
Income Tax % of Revenue i0.5%5.6%
Net Income (Profit) i57.13M881.47M
Profit Margin i1.5%16.0%

Balance Sheet & Liquidity Metrics

MetricTATVA (2025)TANFACIND (2025)
Cash & Equivalents i113.74M301.18M
Total Current Assets i2.65B2.46B
Total Current Assets % of Revenue i69.8%44.8%
Total Current Liabilities i960.27M1.08B
Total Current Liabilities % of Revenue i25.3%19.6%
Long-Term Debt i0N/A
Long-Term Debt % of Revenue i0.0%0.0%
Total Shareholders Equity i7.39B3.12B
Retained Earnings i3.09B2.62B
Retained Earnings % of Revenue i81.2%47.6%
Property, Plant & Equipment i551.54M1.68B

Cash Flow Statement Comparison

MetricTATVA (2025)TANFACIND (2025)
Operating Cash Flow i145.88M523.26M
Operating Cash Flow % of Revenue i3.8%9.5%
Capital Expenditures i-761.33M-968.83M
Free Cash Flow i-516.01M-641.87M
FCF Margin i-13.6%-11.7%
Debt Repayment i-32.19MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTATVATANFACIND
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i23.39M19.95M
Float Shares i6.04M7.01M
% Held by Insiders i74.16%70.86%
% Held by Institutions i5.31%0.03%
% Held by Public i20.53%29.11%

Dividend Analysis & Yield Comparison: Tatva Chintan Pharma Chem Limited vs Tanfac Industries Ltd.

MetricTATVATANFACIND
Last 12-Month Dividend i₹1.00₹16.00
Last 12-Month Dividend Yield i0.10%0.34%
3-Year Avg Annual Dividend i₹1.67₹7.50
3-Year Avg Dividend Yield i0.14%0.30%
3-Year Total Dividends i₹5.00₹22.50
Ex-Dividend DateSep 12, 2025Sep 17, 2025